Sonova Holding (OTCMKTS:SONVY) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of Sonova Holding (OTCMKTS:SONVY) have earned an average rating of “Moderate Buy” from the seven analysts that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, three have given a hold rating, one has assigned a buy rating and two have issued a strong buy rating on the company.

Several equities research analysts have issued reports on the company. Morgan Stanley upgraded Sonova from an “underweight” rating to an “equal weight” rating in a research report on Tuesday, June 23rd. Jefferies Financial Group cut Sonova from a “hold” rating to a “moderate sell” rating in a report on Wednesday, March 18th. Citigroup restated a “sell” rating on shares of Sonova in a research note on Wednesday, May 13th. Finally, BNP Paribas Exane raised Sonova from a “strong sell” rating to a “strong-buy” rating in a report on Tuesday, March 10th.

Sonova Trading Up 3.8%

SONVY opened at $50.13 on Friday. The company has a current ratio of 1.75, a quick ratio of 1.43 and a debt-to-equity ratio of 0.51. The firm has a 50-day moving average price of $48.62 and a 200-day moving average price of $49.84. Sonova has a twelve month low of $42.26 and a twelve month high of $61.09.

About Sonova

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.